Euro Coop Position on Antimicrobial Resistance
15.11.2016 17:50:43

In September 2016, the G20 recognised Antimicrobial Resistance as posing “a serious threat to public health, growth and global economic stability”. Antimicrobial Resistance or AMR occurs when microorganisms mutate and become resistant to antimicrobial drugs. As a consequence of these mutations, those medicines that are used currently become ineffective; the illness is prolonged and may even become life-threatening.
Current measures are not enough to counteract AMR. Euro Coop therefore calls on all stakeholders to play their part in order to tackle this important public health threat and to consider AMR as a priority globally.
Find out more about Euro Coop's position here.
Latest Consumer Policy news

Cooperatives Driving Change: Key Events in Brussels, March 2025
As part of the International Year of Cooperatives, a series of impactful events took place in...

EU Deregulation of New GMOs: A Blow to Consumer Rights and Transparency
EU Member States voted in favour of deregulating new genetic techniques (NGTs) , exempting...

Join us at the EESC for the "Driving sustainability through healthy diets" Conference
Euro Coop is pleased to invite you to the "Driving sustainability through healthy...
Latest Consumer Policy stories

Coop Private Label Products Shine at the 2025 European Private Label Awards
The 2025 European Private Label Awards have celebrated the achievements in store brand...

Empowering Consumers for a Sustainable Future: An Interview with HISPACOOP for World Consumer Day
On the occasion of World Consumer Day, we highlight the essential role of consumer...

Celebrating Women in Leadership: Debbie Robinson and Central Co-op’s Commitment to Gender Equality
As we mark International Women’s Day, Euro Coop proudly highlights the invaluable...